Brian Farrer

Brian Farrer has extensive work experience in the pharmaceutical and biotechnology industry. Brian is currently working at Inhalon Biopharma as the Senior Director of Development since July 2021. Prior to that, they spent almost a decade at Liquidia Technologies, where they held various roles including Executive Director of Inhalation Technology from January 2016 to July 2021, and Principal Scientist/Senior Principal Scientist from October 2012 to January 2016.

Before joining Liquidia Technologies, Brian Farrer had a significant role at Merck, where they worked as a Senior Research Chemist/Research Fellow from January 2003 to September 2012. Brian also has academic experience, having served as an NIH Postdoctoral Fellow at the University of Michigan from 1999 to 2003.

Additionally, Brian Farrer demonstrated their leadership and organizational skills as the Founder of the Preclinical Form and Formulation in Drug Discovery Gordon Conference at Gordon Research Conferences from July 2011 to June 2013. Brian successfully wrote proposals, obtained funding, and selected speakers for this biannual conference, which showcased cutting-edge research on the evaluation and development of drug delivery methodologies.

Overall, Brian Farrer has a strong background in research and development within the pharmaceutical industry, with expertise in inhalation technology and drug formulation.

Brian Farrer has an impressive education history. From 1990 to 1994, they attended Northwestern University, where they obtained a Bachelor of Arts degree. Their major fields of study were Chemistry and Mathematics. Following this, from 1994 to 1999, they pursued their higher education at the University of North Carolina at Chapel Hill. During this period, they earned a Doctor of Philosophy degree in Chemistry.